Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
PB Ratio: Discounted Valuation
Trending lower, below historical average.
Left:
||||
Price-to-book ratio
Latest
-1.06
↓ 114% below average
Average (9y)
7.71
Historical baseline
Range
High:80.97
Low:-7.43
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -1.06 | -56.3% |
| 2023 | -0.68 | +47.0% |
| 2022 | -1.28 | -74.1% |
| 2021 | -0.73 | +90.1% |
| 2020 | -7.43 | -109.2% |
| 2019 | 80.97 | +4035.1% |
| 2018 | -2.06 | -132.0% |
| 2017 | 6.44 | +421.6% |
| 2016 | 1.23 | -27.6% |
| 2015 | 1.71 | - |